ArticleHealth science reports2026
Emerging Novel SARS-CoV-2 Subvariants and the Advantages of AI-ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: The world witnessed COVID-19 in 2025 yet again, a resurgence driven by LF.7 and NB.1.8.1 subvariants of JN.1. With Singapore, Hong Kong and Thailand as the epicenter this time, these variants demonstrated rapid geographic spread and temporal dominance across regions including India, the United States (US), the United Kingdom (UK), and China. Genomic surveillance highlighted a sharp peak due to JN.1, followed by rising trends due to LF.7 and NB.1.8.1. Thus, a perspective was assumed aiming to get insights into the shifting epidemiological and transmission dynamics of COVID-19, and how recent advanced technologies like AI-ML could play a key role in deciphering the mutation trends of the novel virus, global genomic surveillance and vaccine research and development. Methods: Literature on recent global COVID cases was sourced online using reliable dedicated search engines. The limited available data from sources was used to get insights. Data were further analyzed, primarily stressing on the molecular-level interplay within the virus and the host, possible technological interventions to know the infectivity and predict the transmission patterns, and the role of artificial intelligence and machine learning integration as solutions for vaccine designing to strategize community health. Results: India recorded over 3900 active cases in the year 2025 till early June. Kerala and Maharashtra contributed the majority of the fresh cases. Most reported cases were clinically mild, but isolated severe outcomes were witnessed, particularly among the high-risk subjects. Despite successful mass vaccination drives, recent transmission suggested a dynamic interplay of the waning immunity, adaptability of the subvariants, and altered public behavioral patterns. Conclusions: Integrated AI-ML tools greatly enhanced the real-time response and resource planning through genome surveillance, predictive modeling, and outbreak predictions. In silico cutting-edge technologies are useful tools facilitating rapid assessment of the spread and strengthening decision-making in public healthcare. Designing AI-assisted strategies and continued monitoring were vital to mitigate threats of infectious diseases in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.